FDA OK's better pneumococcal vaccine
Wednesday, February 24, 2010 - 12:56
in Health & Medicine
WASHINGTON, Feb. 24 (UPI) -- The U.S. Food and Drug Administration says it has approved Prevnar 13, a pneumococcal vaccine for infants and children ages 6 weeks through 5 years.